ATGL vs HCKT

The Advanced Deterministic Scorecard reveals a weak financial health profile with a Piotroski F-Score of 4/9, indicating borderline stability. Despite a strong gross margin of 54.06% and a healthy current ratio of 4.18, the company is unprofitable with deeply negative operating and net margins, collapsing revenue growth of -49.30% YoY, and extremely elevated valuation multiples. The absence of Altman Z-Score and key valuation metrics like Graham Number further underscores data limitations and financial opacity. Recent price performance shows a sharp reversal from long-term gains, with significant declines over the past 6 months and 1 month, suggesting deteriorating market confidence.

HCKT exhibits a dichotomy between strong operational health and poor market performance, highlighted by a strong Piotroski F-Score of 7/9 but a catastrophic 1-year price decline of 51.5%. While earnings growth is robust (64.6% YoY), this is decoupled from revenue, which is contracting (-3.4% YoY), suggesting profitability is driven by cost-cutting rather than organic growth. The dividend is a significant red flag with a payout ratio of 104.35%, rendering it unsustainable. The stock currently trades near its growth-based intrinsic value of $13.57, though it remains well above its defensive Graham Number of $5.3.